Fingerprint
Dive into the research topics of 'A phase 1 and randomized controlled phase 2 trial of the safety and efficacy of the combination of gemcitabine and docetaxel with ontuxizumab (MORAb-004) in metastatic soft-tissue sarcomas'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically